Cargando…

The Important Role of Interleukin-2 in COVID-19

There is controversial literature about the effects of the interleukin-2 (IL-2) cytokine family in COVID-19 pathogenesis and immunity. So we aimed to identify the potential in the role of the IL-2 family in COVID-19. A narrative review search was done through online databases, including PubMed, Scop...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghanbari Naeini, Leila, Abbasi, Laleh, Karimi, Farzaneh, Kokabian, Pajman, Abdi Abyaneh, Fahimeh, Naderi, Delaram
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10465260/
https://www.ncbi.nlm.nih.gov/pubmed/37649897
http://dx.doi.org/10.1155/2023/7097329
_version_ 1785098631111507968
author Ghanbari Naeini, Leila
Abbasi, Laleh
Karimi, Farzaneh
Kokabian, Pajman
Abdi Abyaneh, Fahimeh
Naderi, Delaram
author_facet Ghanbari Naeini, Leila
Abbasi, Laleh
Karimi, Farzaneh
Kokabian, Pajman
Abdi Abyaneh, Fahimeh
Naderi, Delaram
author_sort Ghanbari Naeini, Leila
collection PubMed
description There is controversial literature about the effects of the interleukin-2 (IL-2) cytokine family in COVID-19 pathogenesis and immunity. So we aimed to identify the potential in the role of the IL-2 family in COVID-19. A narrative review search was done through online databases, including PubMed, Scopus, and Web of Science. The search deadline was up to December 2022. We applied no time limits for the searching strategy. After retrieving articles from the databases, the authors summarized the data into two data extraction tables. The first data extraction table described the changes in the IL-2 cytokine family in COVID-19 and the second table described the therapeutic interventions targeting IL-2 family cytokines. The results of the literature on the role of the IL-2 cytokine family do not show a singular rule. IL-2 cytokine family can change during severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Some studies suggest that IL-2 cytokine family rise during the infection and cause severe inflammatory response and cytokine storm. These cytokines are shown to be increased in immunocompromised patients and worsen their prognosis. In individuals without underlying disease, the upregulation of the IL-2 family shows the clinical outcome of the disease and rises with disease severity. However, some other studies show that these cytokines do not significantly change. IL-2 cytokine family is mostly upregulated in healthy individuals who had vaccination, but immunocompromised patients did not show significant changes after a single dose of vaccines, which shows that these patients need booster doses for efficient immunity. IL-2 cytokine family can also be used as immunotherapy agents in COVID-19.
format Online
Article
Text
id pubmed-10465260
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-104652602023-08-30 The Important Role of Interleukin-2 in COVID-19 Ghanbari Naeini, Leila Abbasi, Laleh Karimi, Farzaneh Kokabian, Pajman Abdi Abyaneh, Fahimeh Naderi, Delaram J Immunol Res Review Article There is controversial literature about the effects of the interleukin-2 (IL-2) cytokine family in COVID-19 pathogenesis and immunity. So we aimed to identify the potential in the role of the IL-2 family in COVID-19. A narrative review search was done through online databases, including PubMed, Scopus, and Web of Science. The search deadline was up to December 2022. We applied no time limits for the searching strategy. After retrieving articles from the databases, the authors summarized the data into two data extraction tables. The first data extraction table described the changes in the IL-2 cytokine family in COVID-19 and the second table described the therapeutic interventions targeting IL-2 family cytokines. The results of the literature on the role of the IL-2 cytokine family do not show a singular rule. IL-2 cytokine family can change during severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Some studies suggest that IL-2 cytokine family rise during the infection and cause severe inflammatory response and cytokine storm. These cytokines are shown to be increased in immunocompromised patients and worsen their prognosis. In individuals without underlying disease, the upregulation of the IL-2 family shows the clinical outcome of the disease and rises with disease severity. However, some other studies show that these cytokines do not significantly change. IL-2 cytokine family is mostly upregulated in healthy individuals who had vaccination, but immunocompromised patients did not show significant changes after a single dose of vaccines, which shows that these patients need booster doses for efficient immunity. IL-2 cytokine family can also be used as immunotherapy agents in COVID-19. Hindawi 2023-08-22 /pmc/articles/PMC10465260/ /pubmed/37649897 http://dx.doi.org/10.1155/2023/7097329 Text en Copyright © 2023 Leila Ghanbari Naeini et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Ghanbari Naeini, Leila
Abbasi, Laleh
Karimi, Farzaneh
Kokabian, Pajman
Abdi Abyaneh, Fahimeh
Naderi, Delaram
The Important Role of Interleukin-2 in COVID-19
title The Important Role of Interleukin-2 in COVID-19
title_full The Important Role of Interleukin-2 in COVID-19
title_fullStr The Important Role of Interleukin-2 in COVID-19
title_full_unstemmed The Important Role of Interleukin-2 in COVID-19
title_short The Important Role of Interleukin-2 in COVID-19
title_sort important role of interleukin-2 in covid-19
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10465260/
https://www.ncbi.nlm.nih.gov/pubmed/37649897
http://dx.doi.org/10.1155/2023/7097329
work_keys_str_mv AT ghanbarinaeinileila theimportantroleofinterleukin2incovid19
AT abbasilaleh theimportantroleofinterleukin2incovid19
AT karimifarzaneh theimportantroleofinterleukin2incovid19
AT kokabianpajman theimportantroleofinterleukin2incovid19
AT abdiabyanehfahimeh theimportantroleofinterleukin2incovid19
AT naderidelaram theimportantroleofinterleukin2incovid19
AT ghanbarinaeinileila importantroleofinterleukin2incovid19
AT abbasilaleh importantroleofinterleukin2incovid19
AT karimifarzaneh importantroleofinterleukin2incovid19
AT kokabianpajman importantroleofinterleukin2incovid19
AT abdiabyanehfahimeh importantroleofinterleukin2incovid19
AT naderidelaram importantroleofinterleukin2incovid19